Neuroprotection: extrapolating from neurologic diseases to the eye.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19464671.
- Also identified by DOI 10.1016/j.ajo.2009.03.029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To review the current status of neuroprotection in ophthalmic disease. Perspective. Published and unpublished data on neuroprotection in neurologic and ophthalmologic diseases were reviewed and interpreted. Almost all clinical studies of neuroprotection in neurologic and ophthalmologic disease so far have failed to show efficacy, despite encouraging preclinical studies. Achievement of consensus on how to design and execute translational research in neuroprotection in ophthalmic disease would optimize the use of resources and would hasten the development and approval of effective neuroprotective agents.
Medical subject headings
- Excitatory Amino Acid Antagonists
- Glaucoma, Open-Angle
- Nervous System Diseases
- Neuroprotective Agents
- Optic Nerve Diseases